Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer

Author:

Davies Gerald,Lobanova Liubov,Dawicki Wojciech,Groot Gary,Gordon John R.,Bowen Matthew,Harkness Troy,Arnason TerraORCID

Funder

Canadian Breast Cancer Foundation

Canadian Foundation for Innovation

Saskatchewan Health Research Foundation

Department of Medicine, University of Saskatchewan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference72 articles.

1. New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies;D Westover;J Exp Clin Cancer Res,2015

2. Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer;N Patani;Molecular and cellular endocrinology,2014

3. Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib;HJ Broxterman;Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy,2009

4. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives;Z Binkhathlan;Current cancer drug targets,2013

5. Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies;MI Nounou;Breast Cancer (Auckl),2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3